VC-Backed TetraLogic Pharmaceuticals Names New Leadership Team
TetraLogic Pharmaceuticals said Monday that it has made changes in its leadership team. J. Kevin Buchi has been named president and CEO while Pete A Meyers and Lesley Russell have taken over as CFO and COO respectively. Buchi will be replacing John M. Gill, who will continue to serve on TetraLogic's board of directors. Based in Malvern, Penn., TetraLogic is a biopharmeceutical company. It is backed by Clarus Ventures, HealthCare Ventures, Quaker Partners, Novitas Capital, Nextech Invest Ltd, Hatteras Venture Partners, Pfizer Ventures, Latterell Venture Partners, the Vertical Group, Amgen Ventures and Kammerer Associates.
19 August 2013•4 mins read
